Comparison Study of Standard Care Against Combination of Growth Factors Agents for Low-risk Myelodysplastic Syndromes

Clinical trial NCT01196715 · COMPLETED

Trial details

NCT number: NCT01196715
Sponsor: Barts & The London NHS Trust
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Myelodysplastic Syndrome

Start date: 2010-11-01
Primary completion: 2015-10-31
Enrollment: 360

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.